Investor Relations
Akari Therapeutics was established in 2005 in the UK. The company is currently public and trades on NASDAQ under AKTX.
Akari Therapeutics was established in 2005 in the UK. The company is currently public and trades on NASDAQ under AKTX.
75/76 Wimpole Street London W1G 9RT UK
T: +44 (0)20.8004.0261
E: info@Akaritx.com
135 W 41st Street. 5th Floor New York, NY, 10036
T: 929.274.7510
F: 646.843.9352
E: info@Akaritx.com